Access to medicines

TRIPS waiver for COVID-19 Tools: what are the implications for Africa?

This webinar held on 26 February 2021, hosted by Médecins Sans Frontières (MSF) and Drugs for Neglected Diseases Initiative (DNDi), discusses the implications of the TRIPs waiver proposal for Africa, and why countries should support it.

On the panel: 

  • Mustaqeem De Gama - Counsellor, the Permanent Mission of South Africa in Geneva
  • Dr Hu Yuan Qiong - Senior Legal & Policy Advisor,Médecins Sans Frontières Access Campaign
  • Dr Ahmed Ogwell Ouma - Deputy Director, Africa CDC
  • Moses Mulumba - Executive Director, CEHURD
  • Dr Monique Wasunna – Director, DNDi Africa Region (Closing remarks)
  • Spring Gombe - Programme Manager for Technology Access Partnership at UN Technology Bank for the Least Developed Countries (Moderator)